WAM
AGIO icon

Wolverine Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Wolverine Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-37
Closed -$1K – 1548
2020
Q2 		$1K Buy
+37
New +$1.71K ﹤0.01% 1486

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Asset Management's AGIO Position: Q3 2020 in Review

Wolverine Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2020, closing a stake of 37 shares — an estimated $1K sold.

Wolverine Asset Management first reported a position in AGIO in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 214 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

  • Wolverine Asset Management reported no remaining Agios Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 37 Agios Pharmaceuticals shares in Q3 2020, an estimated $1K.
  • Wolverine Asset Management first reported a position in Agios Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Wolverine Asset Management's Agios Pharmaceuticals position peaked at $1K in Q2 2020.
  • 214 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on Wolverine Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.